You might also like
Tear-off pad on AML with FLT3 mutation
This tear-off pad has been created to provide clear explanations about FLT3-mutated AML for patients.
Find out more
ADMIRAL trial (2019)
Publication
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Find out moreThe AML landscape
Video
Experts Prof. Dr. Jacqueline Cloos (Amsterdam UMC) and Dr. Peter Valk (Erasmus MC) provide an overview of the current AML research and treatment landscape: which knowledge do we have available and how can we implement this in clinical practice? The following topics are addressed: diagnostics, disease progression, prognosis, factors that play a role in successful treatment, and which MRD tests are performed, and why.
Intended for: practitioners
Why: up-to-date knowledge
When: watch now
Language: Dutch with French subtitles
Duration: 12 minutes
MAT-BE-NON-2024-00049 - Latest update April 2024